Issue 11/2017
Content (11 Articles)
Therapeutic antibodies against cancer stem cells: a promising approach
Smarakan Sneha, Rohit Pravin Nagare, Syama Krishna Priya, Chirukandath Sidhanth, Klaus Pors, Trivadi Sundaram Ganesan
Autoimmune diabetes induced by PD-1 inhibitor—retrospective analysis and pathogenesis: a case report and literature review
Marie-Léa Gauci, Pauline Laly, Tiphaine Vidal-Trecan, Barouyr Baroudjian, Jérémy Gottlieb, Nika Madjlessi-Ezra, Laetitia Da Meda, Isabelle Madelaine-Chambrin, Martine Bagot, Nicole Basset-Seguin, Cécile Pages, Samia Mourah, Philippe Boudou, Céleste Lebbé, Jean-François Gautier
Critical biological parameters modulate affinity as a determinant of function in T-cell receptor gene-modified T-cells
Timothy T. Spear, Yuan Wang, Kendra C. Foley, David C. Murray, Gina M. Scurti, Patricia E. Simms, Elizabeth Garrett-Mayer, Lance M. Hellman, Brian M. Baker, Michael I. Nishimura
The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicity
Fiona C. Thistlethwaite, David E. Gilham, Ryan D. Guest, Dominic G. Rothwell, Manon Pillai, Deborah J. Burt, Andrea J. Byatte, Natalia Kirillova, Juan W. Valle, Surinder K. Sharma, Kerry A. Chester, Nigel B. Westwood, Sarah E. R. Halford, Stephen Nabarro, Susan Wan, Eric Austin, Robert E. Hawkins
Circulating myeloid-derived suppressor cells increase in patients undergoing neo-adjuvant chemotherapy for breast cancer
Robert Wesolowski, Megan C. Duggan, Andrew Stiff, Joseph Markowitz, Prashant Trikha, Kala M. Levine, Lynn Schoenfield, Mahmoud Abdel-Rasoul, Rachel Layman, Bhuvaneswari Ramaswamy, Erin R. Macrae, Maryam B. Lustberg, Raquel E. Reinbolt, Ewa Mrozek, John C. Byrd, Michael A. Caligiuri, Thomas A. Mace, William E. Carson III
CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases
Erna-Elise Paulsen, Thomas K. Kilvaer, Mehrdad Rakaee, Elin Richardsen, Sigurd M. Hald, Sigve Andersen, Lill-Tove Busund, Roy M. Bremnes, Tom Donnem
Cerebellar degeneration-related proteins 2 and 2-like are present in ovarian cancer in patients with and without Yo antibodies
Margrethe Raspotnig, Mette Haugen, Maria Thorsteinsdottir, Ingunn Stefansson, Helga B. Salvesen, Anette Storstein, Christian A. Vedeler
Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy
Frida Ewald Sander, Malin Nilsson, Anna Rydström, Johan Aurelius, Rebecca E. Riise, Charlotta Movitz, Elin Bernson, Roberta Kiffin, Anders Ståhlberg, Mats Brune, Robin Foà, Kristoffer Hellstrand, Fredrik B. Thorén, Anna Martner
IL-4 blockade alters the tumor microenvironment and augments the response to cancer immunotherapy in a mouse model
Shuku-ei Ito, Hidekazu Shirota, Yuki Kasahara, Ken Saijo, Chikashi Ishioka
“Tumor immunology meets oncology (TIMO) XII”, April 28th–30th 2016, Halle/Saale, Germany
Barbara Seliger
CAR T cells targeting solid tumors: carcinoembryonic antigen (CEA) proves to be a safe target
Astrid Holzinger, Hinrich Abken